This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Indiana University, Other. Active years: 2013-2026.
Company Filing History:
3 out of 804 
1 out of 834,350 Years Active: 2013-2026
Title: Trefford L Simpson: Innovator in Tactile Sensitivity Measurement
Introduction
Trefford L Simpson is a notable inventor based in Waterloo, Canada. He has made significant contributions to the field of medical technology, particularly in the assessment of tactile sensitivity and the treatment of dry eye conditions. With a total of 4 patents to his name, Simpson's work has the potential to impact patient care and treatment efficacy.
Latest Patents
One of his latest inventions is the "Pneumatic esthesiometer with gas pulse-conditioner." This device is designed to measure the tactile sensitivity of a patient's eye. It includes a pressurized gas supply system, a control system, and a pulse-conditioner. The pressurized gas supply system is configured to provide a flow of pressurized gases, while the control system manages this flow effectively. Another significant patent is the "Method for assessing the efficacy of treatments for dry eye." This invention encompasses methods for measuring the connection between neurosensory abnormalities and dry eye, as well as testing the efficacy of both new and existing therapies for treating dry eye symptoms in patients.
Career Highlights
Throughout his career, Trefford L Simpson has worked with reputable institutions, including Indiana University. His innovative approaches and dedication to improving medical technology have established him as a respected figure in his field.
Collaborations
Simpson has collaborated with notable colleagues such as Ping Situ and Carolyn G Begley. Their combined expertise has contributed to the advancement of research and development in medical technologies.
Conclusion
Trefford L Simpson's contributions to the field of medical technology, particularly in tactile sensitivity measurement and dry eye treatment, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical science and enhancing therapeutic outcomes.